Early Phase 1 GBM Clinical Trials

2 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–2 of 2 trials

Recruiting

Early Phase 1

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

Brain MetastasasesGlioblastoma (GBM)

Nader Sanai15 enrolled1 locationNCT07268053

Recruiting

Early Phase 1

Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients

Glioblastoma (GBM)

Zhongnan Hospital15 enrolled1 locationNCT06757153